HomeInsightsPE

Lasa Supergenerics Ltd PE Ratio

Lasa Supergenerics Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

2.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Lasa Supergenerics Ltd

NSE: LASA

PE

-

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Lasa Supergenerics Ltd is 0 as of 24 Nov 15:30 PM .
  • The P/E Ratio of Lasa Supergenerics Ltd changed from 31.9 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Latest Trading Price of Lasa Supergenerics Ltd is ₹ 24.82 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Lasa Supergenerics Ltd

No data available

Company Fundamentals for Lasa Supergenerics Ltd

No data available

Image

Lasa Supergenerics Ltd

NSE: LASA

Share Price

₹ 24.82

0.47 (1.93%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Lasa Supergenerics Ltd

1M

1Y

3Y

5Y

Monitoring Lasa Supergenerics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202424.82
21 Nov 202424.35
19 Nov 202424.84
18 Nov 202425.33
14 Nov 202425.84
13 Nov 202426.36
12 Nov 202426.89
11 Nov 202427.43
08 Nov 202427.98
07 Nov 202427.44

SWOT Analysis Of Lasa Supergenerics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Lasa Supergenerics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lasa Supergenerics Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Lasa Supergenerics Ltd0124
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Lasa Supergenerics Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lasa Supergenerics Ltd

No data available

* All values are in crore

Historical Revenue of Lasa Supergenerics Ltd

No data available

* All values are in crore

Historical EBITDA of Lasa Supergenerics Ltd

No data available

* All values are in crore

Historical Net Profit of Lasa Supergenerics Ltd

No data available

* All values are in crore

Historical Dividend Payout of Lasa Supergenerics Ltd

No data available

* All values are in %

About Lasa Supergenerics Ltd

  • Lasa Supergenerics Limited was incorporated on March 11, 2016.
  • The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
  • The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
  • The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
  • It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

Lasa Supergenerics Ltd News Hub

News

Lasa Supergenerics reports standalone net loss of Rs 2.73 crore in the June 2024 quarter

Net Loss of Lasa Supergenerics reported to Rs 2.73 crore in the quarter ended June 2024 as...

Read more

2024-08-16 00:00:00

News

Lasa Supergenerics schedules board meeting

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 14 Augu...

Read more

2024-08-09 00:00:00

News

Lasa Supergenerics AGM scheduled

Lasa Supergenerics announced that the 9th Annual General Meeting (AGM) of the company will...

Read more

2024-09-20 00:00:00

News

Lasa Supergenerics to conduct board meeting

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

2024-11-09 00:00:00

News

Lasa Supergenerics reports standalone net loss of Rs 3.23 crore in the September 2024 quarter

Net Loss of Lasa Supergenerics reported to Rs 3.23 crore in the quarter ended September 20...

Read more

2024-11-15 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lasa Supergenerics Ltd

What is the current PE Ratio of Lasa Supergenerics Ltd?

The Current PE Ratio of Lasa Supergenerics Ltd is 0.0 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Lasa Supergenerics Ltd last year?

The PE Ratio of Lasa Supergenerics Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Lasa Supergenerics Ltd indicate about its stock?

The PE Ratio of Lasa Supergenerics Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Lasa Supergenerics Ltd.

What is the PE Ratio Growth of Lasa Supergenerics Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lasa Supergenerics Ltd grew by -% whereas, the EPS ratio grew by 16.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*